BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2026.
World J Psychiatry. Feb 19, 2026; 16(2): 113123
Published online Feb 19, 2026. doi: 10.5498/wjp.v16.i2.113123
Figure 1
Figure 1 Inflammatory factors and indicators of intestinal mucosal barrier function. A-C: Inflammatory factor levels: Tumor necrosis factor-α levels before and after treatment (A); Interleukin-6 levels before and after treatment (B); and interleukin-10 levels before and after treatment (C); D-F: Indicators of intestinal mucosal barrier function: Diamine oxidase levels before and after treatment (D); D-lactate levels before and after treatment (E); Lipopolysaccharides levels before and after treatment (F). aP < 0.05; bP < 0.01; cP < 0.001. NS: Not significant; TNF-α: Tumor necrosis factor-α; IL-6: Interleukin-6; IL-10: Interleukin-10; DAO: Diamine oxidase; LPS: Lipopolysaccharides.
Figure 2
Figure 2 Psychological state score. A: Self-rating anxiety scale scores before and after treatment; B: Self-rating depression scale scores before and after treatment. aP < 0.05; bP < 0.01. NS: Not significant; SAS: Self-rating anxiety scale; SDS: Self-rating depression scale.<br/>